Global Subcutaneous Immunoglobulins Market Insights and Forecast to 2028

TABLE OF CONTENTS

1 Study Coverage

• 1.1 Subcutaneous Immunoglobulins Product Introduction
• 1.2 Market by Purity
  • 1.2.1 Global Subcutaneous Immunoglobulins Market Size Growth Rate by Purity, 2017 VS 2021 VS 2028
  • 1.2.2 0.1
  • 1.2.3 0.2
• 1.3 Market by Application
  • 1.3.1 Global Subcutaneous Immunoglobulins Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
  • 1.3.2 Primary Immunodeficiency
  • 1.3.3 Secondary Immunodeficiency
  • 1.3.4 Others
• 1.4 Study Objectives
• 1.5 Years Considered

2 Executive Summary

• 2.1 Global Subcutaneous Immunoglobulins Sales Estimates and Forecasts 2017-2028
• 2.2 Global Subcutaneous Immunoglobulins Revenue Estimates and Forecasts 2017-2028
• 2.3 Global Subcutaneous Immunoglobulins Revenue by Region: 2017 VS 2021 VS 2028
• 2.4 Global Subcutaneous Immunoglobulins Sales by Region
  • 2.4.1 Global Subcutaneous Immunoglobulins Sales by Region (2017-2022)
  • 2.4.2 Global Sales Subcutaneous Immunoglobulins by Region (2023-2028)
• 2.5 Global Subcutaneous Immunoglobulins Revenue by Region
  • 2.5.1 Global Subcutaneous Immunoglobulins Revenue by Region (2017-2022)
  • 2.5.2 Global Subcutaneous Immunoglobulins Revenue by Region (2023-2028)
• 2.6 North America
• 2.7 Europe
• 2.8 Asia-Pacific
• 2.9 Latin America
• 2.10 Middle East & Africa

3 Competition by Manufacturers

• 3.1 Global Subcutaneous Immunoglobulins Sales by Manufacturers
  • 3.1.1 Global Top Subcutaneous Immunoglobulins Manufacturers by Sales (2017-2022)
  • 3.1.2 Global Subcutaneous Immunoglobulins Sales Market Share by Manufacturers (2017-2022)
  • 3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Subcutaneous Immunoglobulins in 2021
• 3.2 Global Subcutaneous Immunoglobulins Revenue by Manufacturers
  • 3.2.1 Global Subcutaneous Immunoglobulins Revenue by Manufacturers (2017-2022)
  • 3.2.2 Global Subcutaneous Immunoglobulins Revenue Market Share by Manufacturers (2017-2022)
  • 3.2.3 Global Top 10 and Top 5 Companies by Subcutaneous Immunoglobulins Revenue in 2021
• 3.3 Global Subcutaneous Immunoglobulins Sales Price by Manufacturers (2017-2022)
• 3.4 Analysis of Competitive Landscape
  • 3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
  • 3.4.2 Global Subcutaneous Immunoglobulins Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
  • 3.4.3 Global Subcutaneous Immunoglobulins Manufacturers Geographical Distribution
• 3.5 Mergers & Acquisitions, Expansion Plans

4 Market Size by Purity

• 4.1 Global Subcutaneous Immunoglobulins Sales by Purity
  • 4.1.1 Global Subcutaneous Immunoglobulins Historical Sales by Purity (2017-2022)
  • 4.1.2 Global Subcutaneous Immunoglobulins Forecasted Sales by Purity (2023-2028)
  • 4.1.3 Global Subcutaneous Immunoglobulins Sales Market Share by Purity (2017-2028)
• 4.2 Global Subcutaneous Immunoglobulins Revenue by Purity
  • 4.2.1 Global Subcutaneous Immunoglobulins Historical Revenue by Purity (2017-2022)
  • 4.2.2 Global Subcutaneous Immunoglobulins Forecasted Revenue by Purity (2023-2028)
  • 4.2.3 Global Subcutaneous Immunoglobulins Revenue Market Share by Purity (2017-2028)
• 4.3 Global Subcutaneous Immunoglobulins Price by Purity
  • 4.3.1 Global Subcutaneous Immunoglobulins Price by Purity (2017-2022)
  • 4.3.2 Global Subcutaneous Immunoglobulins Price Forecast by Purity (2023-2028)

5 Market Size by Application

• 5.1 Global Subcutaneous Immunoglobulins Sales by Application
  • 5.1.1 Global Subcutaneous Immunoglobulins Historical Sales by Application (2017-2022)
  • 5.1.2 Global Subcutaneous Immunoglobulins Forecasted Sales by Application (2023-2028)
  • 5.1.3 Global Subcutaneous Immunoglobulins Sales Market Share by Application (2017-2028)
• 5.2 Global Subcutaneous Immunoglobulins Revenue by Application
  • 5.2.1 Global Subcutaneous Immunoglobulins Historical Revenue by Application (2017-2022)
  • 5.2.2 Global Subcutaneous Immunoglobulins Forecasted Revenue by Application (2023-2028)
  • 5.2.3 Global Subcutaneous Immunoglobulins Revenue Market Share by Application (2017-2028)
• 5.3 Global Subcutaneous Immunoglobulins Price by Application
  • 5.3.1 Global Subcutaneous Immunoglobulins Price by Application (2017-2022)
  • 5.3.2 Global Subcutaneous Immunoglobulins Price Forecast by Application (2023-2028)

6 North America

• 6.1 North America Subcutaneous Immunoglobulins Market Size by Purity
  • 6.1.1 North America Subcutaneous Immunoglobulins Sales by Purity (2017-2028)
  • 6.1.2 North America Subcutaneous Immunoglobulins Revenue by Purity (2017-2028)
• 6.2 North America Subcutaneous Immunoglobulins Market Size by Application
  • 6.2.1 North America Subcutaneous Immunoglobulins Sales by Application (2017-2028)
  • 6.2.2 North America Subcutaneous Immunoglobulins Revenue by Application (2017-2028)
• 6.3 North America Subcutaneous Immunoglobulins Market Size by Country
  • 6.3.1 North America Subcutaneous Immunoglobulins Sales by Country (2017-2028)
  • 6.3.2 North America Subcutaneous Immunoglobulins Revenue by Country (2017-2028)
  • 6.3.3 U.S.
  • 6.3.4 Canada

7 Europe

• 7.1 Europe Subcutaneous Immunoglobulins Market Size by Purity
  • 7.1.1 Europe Subcutaneous Immunoglobulins Sales by Purity (2017-2028)
  • 7.1.2 Europe Subcutaneous Immunoglobulins Revenue by Purity (2017-2028)
• 7.2 Europe Subcutaneous Immunoglobulins Market Size by Application
  • 7.2.1 Europe Subcutaneous Immunoglobulins Sales by Application (2017-2028)
  • 7.2.2 Europe Subcutaneous Immunoglobulins Revenue by Application (2017-2028)
• 7.3 Europe Subcutaneous Immunoglobulins Market Size by Country
  • 7.3.1 Europe Subcutaneous Immunoglobulins Sales by Country (2017-2028)
  • 7.3.2 Europe Subcutaneous Immunoglobulins Revenue by Country (2017-2028)
  • 7.3.3 Germany
  • 7.3.4 France
  • 7.3.5 U.K.
  • 7.3.6 Italy
  • 7.3.7 Russia

8 Asia Pacific

• 8.1 Asia Pacific Subcutaneous Immunoglobulins Market Size by Purity
  • 8.1.1 Asia Pacific Subcutaneous Immunoglobulins Sales by Purity (2017-2028)
  • 8.1.2 Asia Pacific Subcutaneous Immunoglobulins Revenue by Purity (2017-2028)
• 8.2 Asia Pacific Subcutaneous Immunoglobulins Market Size by Application
  • 8.2.1 Asia Pacific Subcutaneous Immunoglobulins Sales by Application (2017-2028)
  • 8.2.2 Asia Pacific Subcutaneous Immunoglobulins Revenue by Application (2017-2028)
• 8.3 Asia Pacific Subcutaneous Immunoglobulins Market Size by Region
  • 8.3.1 Asia Pacific Subcutaneous Immunoglobulins Sales by Region (2017-2028)
  • 8.3.2 Asia Pacific Subcutaneous Immunoglobulins Revenue by Region (2017-2028)
  • 8.3.3 China
  • 8.3.4 Japan
  • 8.3.5 South Korea
  • 8.3.6 India
  • 8.3.7 Australia
  • 8.3.8 China Taiwan
  • 8.3.9 Indonesia
  • 8.3.10 Thailand
  • 8.3.11 Malaysia

9 Latin America

• 9.1 Latin America Subcutaneous Immunoglobulins Market Size by Purity
  • 9.1.1 Latin America Subcutaneous Immunoglobulins Sales by Purity (2017-2028)
  • 9.1.2 Latin America Subcutaneous Immunoglobulins Revenue by Purity (2017-2028)
• 9.2 Latin America Subcutaneous Immunoglobulins Market Size by Application
  • 9.2.1 Latin America Subcutaneous Immunoglobulins Sales by Application (2017-2028)
  • 9.2.2 Latin America Subcutaneous Immunoglobulins Revenue by Application (2017-2028)
• 9.3 Latin America Subcutaneous Immunoglobulins Market Size by Country
  • 9.3.1 Latin America Subcutaneous Immunoglobulins Sales by Country (2017-2028)
  • 9.3.2 Latin America Subcutaneous Immunoglobulins Revenue by Country (2017-2028)
  • 9.3.3 Mexico
  • 9.3.4 Brazil
  • 9.3.5 Argentina

10 Middle East and Africa

• 10.1 Middle East and Africa Subcutaneous Immunoglobulins Market Size by Purity
  • 10.1.1 Middle East and Africa Subcutaneous Immunoglobulins Sales by Purity (2017-2028)
  • 10.1.2 Middle East and Africa Subcutaneous Immunoglobulins Revenue by Purity (2017-2028)
• 10.2 Middle East and Africa Subcutaneous Immunoglobulins Market Size by Application
  • 10.2.1 Middle East and Africa Subcutaneous Immunoglobulins Sales by Application (2017-2028)
  • 10.2.2 Middle East and Africa Subcutaneous Immunoglobulins Revenue by Application (2017-2028)
• 10.3 Middle East and Africa Subcutaneous Immunoglobulins Market Size by Country
  • 10.3.1 Middle East and Africa Subcutaneous Immunoglobulins Sales by Country (2017-2028)
  • 10.3.2 Middle East and Africa Subcutaneous Immunoglobulins Revenue by Country (2017-2028)
  • 10.3.3 Turkey
  • 10.3.4 Saudi Arabia

11 Company Profiles

• 11.1 Shire (Baxalta)
  • 11.1.1 Shire (Baxalta) Corporation Information
  • 11.1.2 Shire (Baxalta) Overview
  • 11.1.3 Shire (Baxalta) Subcutaneous Immunoglobulins Sales, Price, Revenue and Gross Margin (2017-2022)
  • 11.1.4 Shire (Baxalta) Subcutaneous Immunoglobulins Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.1.5 Shire (Baxalta) Recent Developments
• 11.2 Grifols
  • 11.2.1 Grifols Corporation Information
  • 11.2.2 Grifols Overview
  • 11.2.3 Grifols Subcutaneous Immunoglobulins Sales, Price, Revenue and Gross Margin (2017-2022)
  • 11.2.4 Grifols Subcutaneous Immunoglobulins Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.2.5 Grifols Recent Developments
• 11.3 CSL
  • 11.3.1 CSL Corporation Information
  • 11.3.2 CSL Overview
  • 11.3.3 CSL Subcutaneous Immunoglobulins Sales, Price, Revenue and Gross Margin (2017-2022)
  • 11.3.4 CSL Subcutaneous Immunoglobulins Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.3.5 CSL Recent Developments

12 Industry Chain and Sales Channels Analysis

• 12.1 Subcutaneous Immunoglobulins Industry Chain Analysis
• 12.2 Subcutaneous Immunoglobulins Key Raw Materials
  • 12.2.1 Key Raw Materials
  • 12.2.2 Raw Materials Key Suppliers
• 12.3 Subcutaneous Immunoglobulins Production Mode & Process
• 12.4 Subcutaneous Immunoglobulins Sales and Marketing
  • 12.4.1 Subcutaneous Immunoglobulins Sales Channels
  • 12.4.2 Subcutaneous Immunoglobulins Distributors
• 12.5 Subcutaneous Immunoglobulins Customers

13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis

• 13.1 Subcutaneous Immunoglobulins Industry Trends
• 13.2 Subcutaneous Immunoglobulins Market Drivers
• 13.3 Subcutaneous Immunoglobulins Market Challenges
• 13.4 Subcutaneous Immunoglobulins Market Restraints

14 Key Findings in The Global Subcutaneous Immunoglobulins Study

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Author Details
• 15.3 Disclaimer

• Table 1. Global Subcutaneous Immunoglobulins Market Size Growth Rate by Purity, 2017 VS 2021 VS 2028 (US$ Million)
• Table 2. Major Manufacturers of 0.1
• Table 3. Major Manufacturers of 0.2
• Table 4. Global Subcutaneous Immunoglobulins Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
• Table 5. Global Subcutaneous Immunoglobulins Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
• Table 6. Global Subcutaneous Immunoglobulins Sales by Region (2017-2022) & (K Bottle)
• Table 7. Global Subcutaneous Immunoglobulins Sales Market Share by Region (2017-2022)
• Table 8. Global Subcutaneous Immunoglobulins Sales by Region (2023-2028) & (K Bottle)
• Table 9. Global Subcutaneous Immunoglobulins Sales Market Share by Region (2023-2028)
• Table 10. Global Subcutaneous Immunoglobulins Revenue by Region (2017-2022) & (US$ Million)
• Table 11. Global Subcutaneous Immunoglobulins Revenue Market Share by Region (2017-2022)
• Table 12. Global Subcutaneous Immunoglobulins Revenue by Region (2023-2028) & (US$ Million)
• Table 13. Global Subcutaneous Immunoglobulins Revenue Market Share by Region (2023-2028)
• Table 14. Global Subcutaneous Immunoglobulins Sales by Manufacturers (2017-2022) & (K Bottle)
• Table 15. Global Subcutaneous Immunoglobulins Sales Share by Manufacturers (2017-2022)
• Table 16. Global Subcutaneous Immunoglobulins Revenue by Manufacturers (2017-2022) & (US$ Million)
• Table 17. Global Subcutaneous Immunoglobulins Revenue Share by Manufacturers (2017-2022)
• Table 18. Subcutaneous Immunoglobulins Price by Manufacturers (2017-2022) &(USD/Bottle)
• Table 19. Global Subcutaneous Immunoglobulins Manufacturers Market Concentration Ratio (CR5 and HHI)
• Table 20. Global Subcutaneous Immunoglobulins by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Subcutaneous Immunoglobulins as of 2021)
• Table 21. Subcutaneous Immunoglobulins Manufacturing Base Distribution and Headquarters
• Table 22. Manufacturers Subcutaneous Immunoglobulins Product Offered
• Table 23. Date of Manufacturers Enter into Subcutaneous Immunoglobulins Market
• Table 24. Mergers & Acquisitions, Expansion Plans
• Table 25. Global Subcutaneous Immunoglobulins Sales by Purity (2017-2022) & (K Bottle)
• Table 26. Global Subcutaneous Immunoglobulins Sales by Purity (2023-2028) & (K Bottle)
• Table 27. Global Subcutaneous Immunoglobulins Sales Share by Purity (2017-2022)
• Table 28. Global Subcutaneous Immunoglobulins Sales Share by Purity (2023-2028)
• Table 29. Global Subcutaneous Immunoglobulins Revenue by Purity (2017-2022) & (US$ Million)
• Table 30. Global Subcutaneous Immunoglobulins Revenue by Purity (2023-2028) & (US$ Million)
• Table 31. Global Subcutaneous Immunoglobulins Revenue Share by Purity (2017-2022)
• Table 32. Global Subcutaneous Immunoglobulins Revenue Share by Purity (2023-2028)
• Table 33. Subcutaneous Immunoglobulins Price by Purity (2017-2022) & (USD/Bottle)
• Table 34. Global Subcutaneous Immunoglobulins Price Forecast by Purity (2023-2028) & (USD/Bottle)
• Table 35. Global Subcutaneous Immunoglobulins Sales by Application (2017-2022) & (K Bottle)
• Table 36. Global Subcutaneous Immunoglobulins Sales by Application (2023-2028) & (K Bottle)
• Table 37. Global Subcutaneous Immunoglobulins Sales Share by Application (2017-2022)
• Table 38. Global Subcutaneous Immunoglobulins Sales Share by Application (2023-2028)
• Table 39. Global Subcutaneous Immunoglobulins Revenue by Application (2017-2022) & (US$ Million)
• Table 40. Global Subcutaneous Immunoglobulins Revenue by Application (2023-2028) & (US$ Million)
• Table 41. Global Subcutaneous Immunoglobulins Revenue Share by Application (2017-2022)
• Table 42. Global Subcutaneous Immunoglobulins Revenue Share by Application (2023-2028)
• Table 43. Subcutaneous Immunoglobulins Price by Application (2017-2022) & (USD/Bottle)
• Table 44. Global Subcutaneous Immunoglobulins Price Forecast by Application (2023-2028) & (USD/Bottle)
• Table 45. North America Subcutaneous Immunoglobulins Sales by Purity (2017-2022) & (K Bottle)
• Table 46. North America Subcutaneous Immunoglobulins Sales by Purity (2023-2028) & (K Bottle)
• Table 47. North America Subcutaneous Immunoglobulins Revenue by Purity (2017-2022) & (US$ Million)
• Table 48. North America Subcutaneous Immunoglobulins Revenue by Purity (2023-2028) & (US$ Million)
• Table 49. North America Subcutaneous Immunoglobulins Sales by Application (2017-2022) & (K Bottle)
• Table 50. North America Subcutaneous Immunoglobulins Sales by Application (2023-2028) & (K Bottle)
• Table 51. North America Subcutaneous Immunoglobulins Revenue by Application (2017-2022) & (US$ Million)
• Table 52. North America Subcutaneous Immunoglobulins Revenue by Application (2023-2028) & (US$ Million)
• Table 53. North America Subcutaneous Immunoglobulins Sales by Country (2017-2022) & (K Bottle)
• Table 54. North America Subcutaneous Immunoglobulins Sales by Country (2023-2028) & (K Bottle)
• Table 55. North America Subcutaneous Immunoglobulins Revenue by Country (2017-2022) & (US$ Million)
• Table 56. North America Subcutaneous Immunoglobulins Revenue by Country (2023-2028) & (US$ Million)
• Table 57. Europe Subcutaneous Immunoglobulins Sales by Purity (2017-2022) & (K Bottle)
• Table 58. Europe Subcutaneous Immunoglobulins Sales by Purity (2023-2028) & (K Bottle)
• Table 59. Europe Subcutaneous Immunoglobulins Revenue by Purity (2017-2022) & (US$ Million)
• Table 60. Europe Subcutaneous Immunoglobulins Revenue by Purity (2023-2028) & (US$ Million)
• Table 61. Europe Subcutaneous Immunoglobulins Sales by Application (2017-2022) & (K Bottle)
• Table 62. Europe Subcutaneous Immunoglobulins Sales by Application (2023-2028) & (K Bottle)
• Table 63. Europe Subcutaneous Immunoglobulins Revenue by Application (2017-2022) & (US$ Million)
• Table 64. Europe Subcutaneous Immunoglobulins Revenue by Application (2023-2028) & (US$ Million)
• Table 65. Europe Subcutaneous Immunoglobulins Sales by Country (2017-2022) & (K Bottle)
• Table 66. Europe Subcutaneous Immunoglobulins Sales by Country (2023-2028) & (K Bottle)
• Table 67. Europe Subcutaneous Immunoglobulins Revenue by Country (2017-2022) & (US$ Million)
• Table 68. Europe Subcutaneous Immunoglobulins Revenue by Country (2023-2028) & (US$ Million)
• Table 69. Asia Pacific Subcutaneous Immunoglobulins Sales by Purity (2017-2022) & (K Bottle)
• Table 70. Asia Pacific Subcutaneous Immunoglobulins Sales by Purity (2023-2028) & (K Bottle)
• Table 71. Asia Pacific Subcutaneous Immunoglobulins Revenue by Purity (2017-2022) & (US$ Million)
• Table 72. Asia Pacific Subcutaneous Immunoglobulins Revenue by Purity (2023-2028) & (US$ Million)
• Table 73. Asia Pacific Subcutaneous Immunoglobulins Sales by Application (2017-2022) & (K Bottle)
• Table 74. Asia Pacific Subcutaneous Immunoglobulins Sales by Application (2023-2028) & (K Bottle)
• Table 75. Asia Pacific Subcutaneous Immunoglobulins Revenue by Application (2017-2022) & (US$ Million)
• Table 76. Asia Pacific Subcutaneous Immunoglobulins Revenue by Application (2023-2028) & (US$ Million)
• Table 77. Asia Pacific Subcutaneous Immunoglobulins Sales by Region (2017-2022) & (K Bottle)
• Table 78. Asia Pacific Subcutaneous Immunoglobulins Sales by Region (2023-2028) & (K Bottle)
• Table 79. Asia Pacific Subcutaneous Immunoglobulins Revenue by Region (2017-2022) & (US$ Million)
• Table 80. Asia Pacific Subcutaneous Immunoglobulins Revenue by Region (2023-2028) & (US$ Million)
• Table 81. Latin America Subcutaneous Immunoglobulins Sales by Purity (2017-2022) & (K Bottle)
• Table 82. Latin America Subcutaneous Immunoglobulins Sales by Purity (2023-2028) & (K Bottle)
• Table 83. Latin America Subcutaneous Immunoglobulins Revenue by Purity (2017-2022) & (US$ Million)
• Table 84. Latin America Subcutaneous Immunoglobulins Revenue by Purity (2023-2028) & (US$ Million)
• Table 85. Latin America Subcutaneous Immunoglobulins Sales by Application (2017-2022) & (K Bottle)
• Table 86. Latin America Subcutaneous Immunoglobulins Sales by Application (2023-2028) & (K Bottle)
• Table 87. Latin America Subcutaneous Immunoglobulins Revenue by Application (2017-2022) & (US$ Million)
• Table 88. Latin America Subcutaneous Immunoglobulins Revenue by Application (2023-2028) & (US$ Million)
• Table 89. Latin America Subcutaneous Immunoglobulins Sales by Country (2017-2022) & (K Bottle)
• Table 90. Latin America Subcutaneous Immunoglobulins Sales by Country (2023-2028) & (K Bottle)
• Table 91. Latin America Subcutaneous Immunoglobulins Revenue by Country (2017-2022) & (US$ Million)
• Table 92. Latin America Subcutaneous Immunoglobulins Revenue by Country (2023-2028) & (US$ Million)
• Table 93. Middle East and Africa Subcutaneous Immunoglobulins Sales by Purity (2017-2022) & (K Bottle)
• Table 94. Middle East and Africa Subcutaneous Immunoglobulins Sales by Purity (2023-2028) & (K Bottle)
• Table 95. Middle East and Africa Subcutaneous Immunoglobulins Revenue by Purity (2017-2022) & (US$ Million)
• Table 96. Middle East and Africa Subcutaneous Immunoglobulins Revenue by Purity (2023-2028) & (US$ Million)
• Table 97. Middle East and Africa Subcutaneous Immunoglobulins Sales by Application (2017-2022) & (K Bottle)
• Table 98. Middle East and Africa Subcutaneous Immunoglobulins Sales by Application (2023-2028) & (K Bottle)
• Table 99. Middle East and Africa Subcutaneous Immunoglobulins Revenue by Application (2017-2022) & (US$ Million)
• Table 100. Middle East and Africa Subcutaneous Immunoglobulins Revenue by Application (2023-2028) & (US$ Million)
• Table 101. Middle East and Africa Subcutaneous Immunoglobulins Sales by Country (2017-2022) & (K Bottle)
• Table 102. Middle East and Africa Subcutaneous Immunoglobulins Sales by Country (2023-2028) & (K Bottle)
• Table 103. Middle East and Africa Subcutaneous Immunoglobulins Revenue by Country (2017-2022) & (US$ Million)
• Table 104. Middle East and Africa Subcutaneous Immunoglobulins Revenue by Country (2023-2028) & (US$ Million)
• Table 105. Shire (Baxalta) Corporation Information
• Table 106. Shire (Baxalta) Description and Major Businesses
• Table 107. Shire (Baxalta) Subcutaneous Immunoglobulins Sales (K Bottle), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2017-2022)
• Table 108. Shire (Baxalta) Subcutaneous Immunoglobulins Product Model Numbers, Pictures, Descriptions and Specifications
• Table 109. Shire (Baxalta) Recent Developments
• Table 110. Grifols Corporation Information
• Table 111. Grifols Description and Major Businesses
• Table 112. Grifols Subcutaneous Immunoglobulins Sales (K Bottle), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2017-2022)
• Table 113. Grifols Subcutaneous Immunoglobulins Product Model Numbers, Pictures, Descriptions and Specifications
• Table 114. Grifols Recent Developments
• Table 115. CSL Corporation Information
• Table 116. CSL Description and Major Businesses
• Table 117. CSL Subcutaneous Immunoglobulins Sales (K Bottle), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2017-2022)
• Table 118. CSL Subcutaneous Immunoglobulins Product Model Numbers, Pictures, Descriptions and Specifications
• Table 119. CSL Recent Developments
• Table 120. Key Raw Materials Lists
• Table 121. Raw Materials Key Suppliers Lists
• Table 122. Subcutaneous Immunoglobulins Distributors List
• Table 123. Subcutaneous Immunoglobulins Customers List
• Table 124. Subcutaneous Immunoglobulins Market Trends
• Table 125. Subcutaneous Immunoglobulins Market Drivers
• Table 126. Subcutaneous Immunoglobulins Market Challenges
• Table 127. Subcutaneous Immunoglobulins Market Restraints
• Table 128. Research Programs/Design for This Report
• Table 129. Key Data Information from Secondary Sources
• Table 130. Key Data Information from Primary Sources

List of Figures

• Figure 1. Subcutaneous Immunoglobulins Product Picture
• Figure 3. Global Subcutaneous Immunoglobulins Market Share by Purity in 2021 & 2028
• Figure 3. 0.1 Product Picture
• Figure 4. 0.2 Product Picture
• Figure 5. Global Subcutaneous Immunoglobulins Market Share by Application in 2021 & 2028
• Figure 6. Primary Immunodeficiency
• Figure 7. Secondary Immunodeficiency
• Figure 8. Others
• Figure 9. Subcutaneous Immunoglobulins Report Years Considered
• Figure 10. Global Subcutaneous Immunoglobulins Sales 2017-2028 (K Bottle)
• Figure 11. Global Subcutaneous Immunoglobulins Revenue, (US$ Million), 2017 VS 2021 VS 2028
• Figure 12. Global Subcutaneous Immunoglobulins Revenue 2017-2028 (US$ Million)
• Figure 13. Global Subcutaneous Immunoglobulins Revenue Market Share by Region in Percentage: 2021 Versus 2028
• Figure 14. Global Subcutaneous Immunoglobulins Sales Market Share by Region (2017-2022)
• Figure 15. Global Subcutaneous Immunoglobulins Sales Market Share by Region (2023-2028)
• Figure 16. North America Subcutaneous Immunoglobulins Sales YoY (2017-2028) & (K Bottle)
• Figure 17. North America Subcutaneous Immunoglobulins Revenue YoY (2017-2028) & (US$ Million)
• Figure 18. Europe Subcutaneous Immunoglobulins Sales YoY (2017-2028) & (K Bottle)
• Figure 19. Europe Subcutaneous Immunoglobulins Revenue YoY (2017-2028) & (US$ Million)
• Figure 20. Asia-Pacific Subcutaneous Immunoglobulins Sales YoY (2017-2028) & (K Bottle)
• Figure 21. Asia-Pacific Subcutaneous Immunoglobulins Revenue YoY (2017-2028) & (US$ Million)
• Figure 22. Latin America Subcutaneous Immunoglobulins Sales YoY (2017-2028) & (K Bottle)
• Figure 23. Latin America Subcutaneous Immunoglobulins Revenue YoY (2017-2028) & (US$ Million)
• Figure 24. Middle East & Africa Subcutaneous Immunoglobulins Sales YoY (2017-2028) & (K Bottle)
• Figure 25. Middle East & Africa Subcutaneous Immunoglobulins Revenue YoY (2017-2028) & (US$ Million)
• Figure 26. The Subcutaneous Immunoglobulins Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
• Figure 27. The Top 5 and 10 Largest Manufacturers of Subcutaneous Immunoglobulins in the World: Market Share by Subcutaneous Immunoglobulins Revenue in 2021
• Figure 28. Global Subcutaneous Immunoglobulins Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
• Figure 29. Global Subcutaneous Immunoglobulins Sales Market Share by Purity (2017-2028)
• Figure 30. Global Subcutaneous Immunoglobulins Revenue Market Share by Purity (2017-2028)
• Figure 31. Global Subcutaneous Immunoglobulins Sales Market Share by Application (2017-2028)
• Figure 32. Global Subcutaneous Immunoglobulins Revenue Market Share by Application (2017-2028)
• Figure 33. North America Subcutaneous Immunoglobulins Sales Market Share by Purity (2017-2028)
• Figure 34. North America Subcutaneous Immunoglobulins Revenue Market Share by Purity (2017-2028)
• Figure 35. North America Subcutaneous Immunoglobulins Sales Market Share by Application (2017-2028)
• Figure 36. North America Subcutaneous Immunoglobulins Revenue Market Share by Application (2017-2028)
• Figure 37. North America Subcutaneous Immunoglobulins Sales Share by Country (2017-2028)
• Figure 38. North America Subcutaneous Immunoglobulins Revenue Share by Country (2017-2028)
• Figure 39. U.S. Subcutaneous Immunoglobulins Revenue (2017-2028) & (US$ Million)
• Figure 40. Canada Subcutaneous Immunoglobulins Revenue (2017-2028) & (US$ Million)
• Figure 41. Europe Subcutaneous Immunoglobulins Sales Market Share by Purity (2017-2028)
• Figure 42. Europe Subcutaneous Immunoglobulins Revenue Market Share by Purity (2017-2028)
• Figure 43. Europe Subcutaneous Immunoglobulins Sales Market Share by Application (2017-2028)
• Figure 44. Europe Subcutaneous Immunoglobulins Revenue Market Share by Application (2017-2028)
• Figure 45. Europe Subcutaneous Immunoglobulins Sales Share by Country (2017-2028)
• Figure 46. Europe Subcutaneous Immunoglobulins Revenue Share by Country (2017-2028)
• Figure 47. Germany Subcutaneous Immunoglobulins Revenue (2017-2028) & (US$ Million)
• Figure 48. France Subcutaneous Immunoglobulins Revenue (2017-2028) & (US$ Million)
• Figure 49. U.K. Subcutaneous Immunoglobulins Revenue (2017-2028) & (US$ Million)
• Figure 50. Italy Subcutaneous Immunoglobulins Revenue (2017-2028) & (US$ Million)
• Figure 51. Russia Subcutaneous Immunoglobulins Revenue (2017-2028) & (US$ Million)
• Figure 52. Asia Pacific Subcutaneous Immunoglobulins Sales Market Share by Purity (2017-2028)
• Figure 53. Asia Pacific Subcutaneous Immunoglobulins Revenue Market Share by Purity (2017-2028)
• Figure 54. Asia Pacific Subcutaneous Immunoglobulins Sales Market Share by Application (2017-2028)
• Figure 55. Asia Pacific Subcutaneous Immunoglobulins Revenue Market Share by Application (2017-2028)
• Figure 56. Asia Pacific Subcutaneous Immunoglobulins Sales Share by Region (2017-2028)
• Figure 57. Asia Pacific Subcutaneous Immunoglobulins Revenue Share by Region (2017-2028)
• Figure 58. China Subcutaneous Immunoglobulins Revenue (2017-2028) & (US$ Million)
• Figure 59. Japan Subcutaneous Immunoglobulins Revenue (2017-2028) & (US$ Million)
• Figure 60. South Korea Subcutaneous Immunoglobulins Revenue (2017-2028) & (US$ Million)
• Figure 61. India Subcutaneous Immunoglobulins Revenue (2017-2028) & (US$ Million)
• Figure 62. Australia Subcutaneous Immunoglobulins Revenue (2017-2028) & (US$ Million)
• Figure 63. China Taiwan Subcutaneous Immunoglobulins Revenue (2017-2028) & (US$ Million)
• Figure 64. Indonesia Subcutaneous Immunoglobulins Revenue (2017-2028) & (US$ Million)
• Figure 65. Thailand Subcutaneous Immunoglobulins Revenue (2017-2028) & (US$ Million)
• Figure 66. Malaysia Subcutaneous Immunoglobulins Revenue (2017-2028) & (US$ Million)
• Figure 67. Latin America Subcutaneous Immunoglobulins Sales Market Share by Purity (2017-2028)
• Figure 68. Latin America Subcutaneous Immunoglobulins Revenue Market Share by Purity (2017-2028)
• Figure 69. Latin America Subcutaneous Immunoglobulins Sales Market Share by Application (2017-2028)
• Figure 70. Latin America Subcutaneous Immunoglobulins Revenue Market Share by Application (2017-2028)
• Figure 71. Latin America Subcutaneous Immunoglobulins Sales Share by Country (2017-2028)
• Figure 72. Latin America Subcutaneous Immunoglobulins Revenue Share by Country (2017-2028)
• Figure 73. Mexico Subcutaneous Immunoglobulins Revenue (2017-2028) & (US$ Million)
• Figure 74. Brazil Subcutaneous Immunoglobulins Revenue (2017-2028) & (US$ Million)
• Figure 75. Argentina Subcutaneous Immunoglobulins Revenue (2017-2028) & (US$ Million)
• Figure 76. Middle East and Africa Subcutaneous Immunoglobulins Sales Market Share by Purity (2017-2028)
• Figure 77. Middle East and Africa Subcutaneous Immunoglobulins Revenue Market Share by Purity (2017-2028)
• Figure 78. Middle East and Africa Subcutaneous Immunoglobulins Sales Market Share by Application (2017-2028)
• Figure 79. Middle East and Africa Subcutaneous Immunoglobulins Revenue Market Share by Application (2017-2028)
• Figure 80. Middle East and Africa Subcutaneous Immunoglobulins Sales Share by Country (2017-2028)
• Figure 81. Middle East and Africa Subcutaneous Immunoglobulins Revenue Share by Country (2017-2028)
• Figure 82. Turkey Subcutaneous Immunoglobulins Revenue (2017-2028) & (US$ Million)
• Figure 83. Saudi Arabia Subcutaneous Immunoglobulins Revenue (2017-2028) & (US$ Million)
• Figure 84. UAE Subcutaneous Immunoglobulins Revenue (2017-2028) & (US$ Million)
• Figure 85. Subcutaneous Immunoglobulins Value Chain
• Figure 86. Subcutaneous Immunoglobulins Production Process
• Figure 87. Channels of Distribution
• Figure 88. Distributors Profiles
• Figure 89. Bottom-up and Top-down Approaches for This Report
• Figure 90. Data Triangulation
• Figure 91. Key Executives Interviewed